| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 03/01/2006 | EP1628666A2 Compouds and uses thereof in modulating amyloid beta |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628619A2 4-aminopyrimidine-5-one |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1278520B1 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1067927B1 Antioxidant stabilizer system for pharmaceutical formulations |
| 03/01/2006 | EP0842923B1 Pyrrole derivatives and medicinal composition |
| 03/01/2006 | CN1742015A Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
| 03/01/2006 | CN1742009A Oxazolidinones as antibacterial agents |
| 03/01/2006 | CN1742008A Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 03/01/2006 | CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors |
| 03/01/2006 | CN1741999A Pyridazinone derivatives as GSK-3beta inhibitors |
| 03/01/2006 | CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 03/01/2006 | CN1740173A Inhibitors of interleukin-1beta converting enzyme |
| 03/01/2006 | CN1740171A Second order non-linear optical chromophore containing indolyl radical and its prepn and application |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1243752C Herbicidal heterocyclic compound |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 03/01/2006 | CN1243745C Process for selectively protecting baccatin derivative and its application in synthesizing tartrialkane |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 02/28/2006 | US7005526 Thioether derivatives |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2006 | US7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005439 Compounds |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | CA2180444C Water soluble onium salt of taxo-diterpenoid |
| 02/23/2006 | WO2006021002A2 Compounds useful for inhibiting chk1 |
| 02/23/2006 | WO2006020879A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | WO2006018855A1 Novel antidiabetic compounds |
| 02/23/2006 | WO2006018682A2 Oxazolidinone derivatives as antimicrobials |
| 02/23/2006 | WO2006018443A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/23/2006 | WO2006018309A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018308A1 5-ht7 receptor antagonists |
| 02/23/2006 | WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor |
| 02/23/2006 | WO2005123688A3 3-aminoindazoles |
| 02/23/2006 | WO2005115145A3 Quinone substituted quinazoline and quinoline kinase inhibitors |
| 02/23/2006 | WO2005079519A3 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
| 02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
| 02/23/2006 | US20060041142 demetallization to prepare of 2,4'-bipyridine, 4-methyl-2-(2'-pyridyl)pyridine, 2,3'-bipyridine, 6-chloro-2-(2'-thienyl)pyridine, or 2-(3'-thienyl)pyridine; synthetic intermediate for fungicides |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041127 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/23/2006 | US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione |
| 02/23/2006 | US20060040995 Method for preparing hydroxypicolinic scid derivatives |
| 02/23/2006 | US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use |
| 02/23/2006 | US20060040973 Novel guanidine mimics as factor Xa inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040950 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/23/2006 | US20060040949 Treating antibiotic resistant bacterial infections; compounds based on quinoline rings; (3S)-2-(3-{[(Benzo[1,2,5]thiadiazol-5-ylmethyl)-amino]-methyl}-piperidin-1-yl)-(1RS)-(6-methoxy-quinolin-4-yl)-ethanol for example |
| 02/23/2006 | US20060040937 N-aroyl cyclic amines as orexin receptor antagonists |
| 02/23/2006 | US20060040936 Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040931 Benzomorpholine derivatives |
| 02/23/2006 | US20060040923 1,1-Diethyl-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea; respiratory syncytial virus; cost efficient replacement for Synagis (palivizumab) used for RSV; respiratory system disorders; asthna; viral diseases; myxoviruses; mumps; flaviviruses; dengue, West Nile, parainfluenza viruses |
| 02/23/2006 | US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders |
| 02/23/2006 | US20060040910 Macrocycles useful in the treatment of Alzheimer's disease |
| 02/23/2006 | US20060040908 Novel chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy |
| 02/23/2006 | CA2581327A1 Intracellular receptor modulator compounds and methods |
| 02/23/2006 | CA2577880A1 Compounds useful for inhibiting chk1 |
| 02/23/2006 | CA2577668A1 Novel antidiabetic compounds |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/23/2006 | CA2575853A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 02/23/2006 | CA2575785A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575771A1 5-ht7 receptor antagonists |
| 02/23/2006 | CA2575561A1 Amido compounds and their use as pharmaceuticals |
| 02/23/2006 | CA2574156A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2573764A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 02/23/2006 | CA2573714A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | CA2567782A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627876A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/22/2006 | EP1627875A1 Method for producing cyclic diamine derivative or salt thereof |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1626969A1 Heterocyclic compounds |
| 02/22/2006 | EP1626968A1 Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 02/22/2006 | EP1626967A1 Substituted pyrazoles |
| 02/22/2006 | EP1626725A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | CN1738815A 整联蛋白靶向的影像剂 Integrin targeting imaging agent |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738804A 吡唑化合物 Pyrazole compounds |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1738796A Bis-aryl sulfonamides |
| 02/22/2006 | CN1738618A Pharmaceutical compositions and their uses |
| 02/22/2006 | CN1242995C Novel compounds, their use and preparation |
| 02/22/2006 | CN1242994C Novel heterocyclic compound and medicinal use thereof |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002020 Oxazolidinone combinatorial libraries, compositions and methods of preparation |
| 02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 02/21/2006 | US7001916 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
| 02/21/2006 | US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |